NovMetaPharma Co., Ltd. (XKON:229500)
8,750.00
+760.00 (9.51%)
At close: May 14, 2026
8.16% (1Y)
| Market Cap | 112.36B +7.6% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 72.92 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,661 |
| Average Volume | 7,903 |
| Open | 9,070.00 |
| Previous Close | 7,990.00 |
| Day's Range | 8,000.00 - 9,070.00 |
| 52-Week Range | 6,800.00 - 17,890.00 |
| Beta | 0.18 |
| RSI | 44.22 |
| Earnings Date | n/a |